{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:52:33Z","timestamp":1790229153158,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T00:00:00Z","timestamp":1337299200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1745-6215-13-61","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T10:14:59Z","timestamp":1337336099000},"source":"Crossref","is-referenced-by-count":28,"title":["A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project"],"prefix":"10.1186","volume":"13","author":[{"given":"Corinne SC","family":"Merle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Sismanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumou Bah","family":"Sow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gninafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lapujade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mame Bocar","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis A","family":"Mitchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Perronne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Portaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Odhiambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Rustomjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lienhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,18]]},"reference":[{"key":"1129_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","volume":"163","author":"EL Corbett","year":"2003","unstructured":"Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003, 163: 1009-1021. 10.1001\/archinte.163.9.1009.","journal-title":"Arch Intern Med"},{"key":"1129_CR2","volume-title":"World Health Statistics Geneva","author":"World Health Organisation","year":"2011","unstructured":"World Health Organisation: World Health Statistics Geneva. 2011, WHO, Switzerland"},{"key":"1129_CR3","volume-title":"Global tuberculosis control","author":"World Healh Organisation","year":"2011","unstructured":"World Healh Organisation: Global tuberculosis control. 2011, WHO, Geneva, Switzerland"},{"key":"1129_CR4","volume-title":"Treatment of tuberculosis guidelines","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Treatment of tuberculosis guidelines. 2009, WHO, Geneva, Switzerland, 4","edition":"4"},{"key":"1129_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0924-8579(02)00239-X","volume":"20","author":"JC Rodriguez","year":"2002","unstructured":"Rodriguez JC, Ruiz M, Lopez M, Royo G: In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents. 2002, 20: 464-467. 10.1016\/S0924-8579(02)00239-X.","journal-title":"Int J Antimicrob Agents"},{"key":"1129_CR6","first-page":"265","volume":"2","author":"SH Gillespie","year":"1998","unstructured":"Gillespie SH, Kennedy N: Fluoroquinolones: a new treatment for tuberculosis?. Int J Tuberc Lung Dis. 1998, 2: 265-271.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"Suppl 1","key":"1129_CR7","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/518663","volume":"196","author":"MK Spigelman","year":"2007","unstructured":"Spigelman MK: New tuberculosis therapeutics: a growing pipeline. J Infect Dis. 2007, 196 (Suppl 1): S28-S34.","journal-title":"J Infect Dis"},{"issue":"1","key":"1129_CR8","first-page":"27","volume":"49","author":"Tuberculosis Research Centre","year":"2002","unstructured":"Tuberculosis Research Centre: Chennai. Shortening short course chemotherapy: a randomized clinical trial for treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Indian J Tuberc. 2002, 49 (1): 27-38.","journal-title":"Indian J Tuberc"},{"key":"1129_CR9","first-page":"128","volume":"12","author":"R Rustomjee","year":"2008","unstructured":"Rustomjee R, Lienhardt C, Kanyok T, Davies GR, Levin J, Mthiyane T, Reddy C, Sturm AW, Sirgel FA, Allen J, Coleman JDJ, Fourie B, Mitchison DA, Gatifloxacin for TB (OFLOTUB) study team: A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2008, 12: 128-138.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1129_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7326\/0003-4819-76-3-112-6-397","volume":"112","author":"DL Combs","year":"1990","unstructured":"Combs DL, O\u2019Brien RJ, Geiter LJ: USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Ann Intern Med. 1990, 112: 397-406.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"1129_CR11","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S1472-9792(08)70039-8","volume":"88","author":"AJ Nunn","year":"2008","unstructured":"Nunn AJ, Phillips PP, Gillespie SH: Design issues in pivotal drug trials for drug sensitive tuberculosis (TB). Tuberculosis (Edinb). 2008, 88 (Suppl 1): S85-S92.","journal-title":"Tuberculosis (Edinb)"},{"key":"1129_CR12","unstructured":"REMOX-TB. [ http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00864383?term=moxifloxacin&rank=1 ].NCT00864383"},{"key":"1129_CR13","unstructured":"RIFAQUIN-Trial. [ http:\/\/www.controlled-trials.com\/ISRCTN44153044\/rifaquin ].ISRCTN44153044"},{"key":"1129_CR14","unstructured":"OFLOTUB. [ http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00216385?term=gatifloxacin&rank=15 ]. NCT00216385"},{"key":"1129_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2125.2001.01397-3.x","volume":"52","author":"Committee for Proprietary Medicinal Product (CPMP) Committee for Proprietary Medicinal Product (CPMP)","year":"2001","unstructured":"Committee for Proprietary Medicinal Product (CPMP) Committee for Proprietary Medicinal Product (CPMP): Points to consider on switching between superiority and non-inferiority. Br J Clin Pharmacol. 2001, 52: 223-228.","journal-title":"Br J Clin Pharmacol"},{"key":"1129_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bmj.2.4582.769","volume":"2","author":"MRC","year":"1948","unstructured":"MRC: STREPTOMYCIN treatment of pulmonary tuberculosis. Br Med J. 1948, 2: 769-782.","journal-title":"Br Med J"},{"key":"1129_CR17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1086\/317504","volume":"31","author":"WJ Burman","year":"2000","unstructured":"Burman WJ, Reves RR: Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis. 2000, 31: 1390-1395. 10.1086\/317504.","journal-title":"Clin Infect Dis"},{"key":"1129_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0041-3879(80)90002-1","volume":"61","author":"DA Mitchison","year":"1980","unstructured":"Mitchison DA, Keyes AB, Edwards EA, Ayuma P, Byfield SP, Nunn AJ: Quality control in tuberculosis bacteriology. 2. The origin of isolated positive cultures from the sputum of patients in four studies of short course chemotherapy in Africa. Tubercle. 1980, 61: 135-144. 10.1016\/0041-3879(80)90002-1.","journal-title":"Tubercle"},{"key":"1129_CR19","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1086\/379616","volume":"37","author":"ML Lambert","year":"2003","unstructured":"Lambert ML, Hasker E, Van Deun A, Roberfroid D, Van der Stuyft P: Rifampin and recurrence of tuberculosis among patients infected with HIV. Clin Infect Dis. 2003, 37: 1719-1720. author reply 1720\u20131712","journal-title":"Clin Infect Dis"},{"key":"1129_CR20","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1473-3099(03)00607-8","volume":"3","author":"ML Lambert","year":"2003","unstructured":"Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P: Recurrence in tuberculosis: relapse or reinfection?. Lancet Infect Dis. 2003, 3: 282-287. 10.1016\/S1473-3099(03)00607-8.","journal-title":"Lancet Infect Dis"},{"key":"1129_CR21","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1128\/JCM.01392-06","volume":"44","author":"P Supply","year":"2006","unstructured":"Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, Bifani P, Kurepina N, Kreiswirth B, Sola C, Rastogi N, Vatin V, Gutierrez MC, Fauville M, Niemann S, Skuce R, Kremer K, Locht C, van Soolingen D: Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol. 2006, 44: 4498-4510. 10.1128\/JCM.01392-06.","journal-title":"J Clin Microbiol"},{"key":"1129_CR22","unstructured":"Fox W, Ellard GA, Mitchison DA: Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946\u20131986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999, \u2009 (Suppl 2): S231-S279."},{"key":"1129_CR23","first-page":"241","volume":"14","author":"AJ Nunn","year":"2010","unstructured":"Nunn AJ, Phillips PP, Mitchison DA: Timing of relapse in short-course chemotherapy trials for tuberculosis. Int J Tuberc Lung Dis. 2010, 14: 241-242.","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-13-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-13-61\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-13-61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T21:59:59Z","timestamp":1642283999000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-13-61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,18]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1129"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-13-61","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,18]]},"article-number":"61"}}